RxDoctor Payments Data

David Franz, MD

Neurology with Special Qualifications in Child Neurology · Cincinnati, OHNPI 1649204207

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,600 of the $3,636 with a category attached, or 99.0%. Biocodex, Inc. accounts for 66.0% of it on its own, with 3 other manufacturers making up the rest.

$3,636in general payments, 2019–2025

Across 6 payments — averaging $606.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biocodex, Inc.$2K
  • Zogenix Inc.$1K
  • Sunovion Pharmaceuticals Inc.$24
  • Neurelis, Inc.$12
$96,303in research payments, 2019–2025

Across 8 payments — averaging $12,038 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$96K

What the payments were for

  • Consulting fees$3,60099%
  • Food & beverage$361%

General payments by program year

20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biocodex, Inc.1$2,400
Zogenix Inc.3$1,200
Sunovion Pharmaceuticals Inc.1$24
Neurelis, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,636 in reported general payments places this provider in the 65th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.

See all neurology with special qualifications in child neurology providers in Ohio

Medicare billing

Part B allowed, 2024
$8,466
Medicare patients
41
Services billed
83

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EpidiolexCannabidiol (Cbd)159$707,289
XcopriCenobamate135$319,505
AfinitorEverolimus12$234,596
Vigabatrin37$229,386
FinteplaFenfluramine Hcl11$158,205
TopamaxTopiramate30$105,999
Everolimus40$89,592
AptiomEslicarbazepine Acetate75$89,254
NayzilamMidazolam34$82,686
DiacomitStiripentol14$60,186
LamictalLamotrigine29$53,292
ValtocoDiazepam26$46,687
BriviactBrivaracetam27$41,170
FycompaPerampanel28$33,266
TrileptalOxcarbazepine12$20,511

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sunovion Pharmaceuticals Inc.Aptiom$24$89,25475 claims
Biocodex, Inc.Diacomit$2,400$60,18614 claims
Neurelis, Inc.Valtoco$12$46,68726 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.

Other neurology with special qualifications in child neurology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →